The following tables represent FY 2003 Current Estimate, FY 2004 Enacted, and the FY 2005 Estimate on a comparable basis. The FY 2003 actuals reflect FDA's actual spending for FY 2003 and have not been adjusted for comparability.
Table of Contents for Comparable Tables
Comparable All Purpose Tables:
FY 2003 current estimate: Shows comparability for the following reallocations in FY 2004: GSA rent; OCC reallocation; Orphan Products; Office of External Relations; Office of Crisis Management; Office of Legislation; the Biologics and Human Drug Program Consolidation; Office of Combination Products; Women's Health Projects; and, the DHHS Human Resources transfer of 104 FTE (93 FTE budget authority and 11 FTE user fees).